The Claim
Vitamin E supplementation in the reported trial showed no cancer risk signal, whereas the SELECT trial reported an increased prostate cancer risk with vitamin E supplementation after extended follow-up, indicating that differences in population, dose, or study design may account for the discrepancy in outcomes.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In one trial, vitamin E supplements did not show a link to cancer, but in another trial called SELECT, vitamin E supplements were linked to higher prostate cancer risk after long-term use. The difference between these results may be due to differences in who was studied, how much vitamin E was given, or how the studies were done.
See the scientific wording
The absence of a cancer risk signal from vitamin E supplementation in this trial contrasts with findings from the SELECT trial, where vitamin E was associated with increased prostate cancer risk after extended follow-up, suggesting differences in population, dose, or study design may explain conflicting results.
Vitamin E reduces harmful oxidative damage in prostate cells, which slows down abnormal cell growth and prevents cancer development. When vitamin E levels are too low or too high, this balance breaks, and cells may grow uncontrollably.
What the research says
1 studyThis big study found that taking vitamin E pills didn’t increase prostate cancer risk in male doctors, which helps explain why another study found a small risk—maybe because the people, doses, or how the studies were done were different.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.